These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 5375358)
21. [Experience in the use of a new drug, amedine, in Parkinsonism]. Vaĭnshtok AB; Oleĭnik LI Sov Med; 1971 Jan; 34(1):40-2. PubMed ID: 5580239 [No Abstract] [Full Text] [Related]
22. [Comparative study of 2 new antiparkinson drugs (UCB 1549 and SD 25)]. Strang RR Nord Med; 1966 Oct; 76(43):1245-7. PubMed ID: 5918116 [No Abstract] [Full Text] [Related]
23. [Bulgarian antiparkinson preparations with a new mechanism of action]. Ganev G; Karamalakov L; Tsekova M Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(12):1864-9. PubMed ID: 6000490 [No Abstract] [Full Text] [Related]
25. [Drug therapy of parkinsonism]. Teräväinen H; Larsen TA Duodecim; 1982; 98(11):892-900. PubMed ID: 6125373 [No Abstract] [Full Text] [Related]
26. Diagnosis and management of Parkinson's disease. Newman RP; Calne DB Geriatrics; 1984 May; 39(5):87-91, 94, 96. PubMed ID: 6714679 [TBL] [Abstract][Full Text] [Related]
27. Preclamol. A "designer drug" in the treatment of advanced Parkinson's disease. Pirtosek Z; Merello M; Carlsson A; Stern G Adv Neurol; 1996; 69():535-40. PubMed ID: 8615177 [No Abstract] [Full Text] [Related]
28. The drug treatment of Parkinson's disease. Drug Ther Bull; 1984 May; 22(10):37-40. PubMed ID: 6745095 [No Abstract] [Full Text] [Related]
29. Mefexamide as an antiparkinson drug. (A double-blind study). Denber HC; Mohr CP Dis Nerv Syst; 1969 Apr; 30(4):250-3. PubMed ID: 4890010 [No Abstract] [Full Text] [Related]
30. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease. Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211 [TBL] [Abstract][Full Text] [Related]
32. Involuntary movement disorders. Still CN Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089 [TBL] [Abstract][Full Text] [Related]
33. [Clinical effects of L-dopa in Parkinson's disease]. Fasano VA Sist Nerv; 1970; 22(2):119-23. PubMed ID: 5504550 [No Abstract] [Full Text] [Related]
34. A double-blind evaluation of S.D. 25 in the treatment of Parkinson's disease. Strang RR Curr Med Drugs; 1966 Dec; 7(4):20-6. PubMed ID: 5976205 [No Abstract] [Full Text] [Related]